Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors

NCT05164744 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT05164744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2021
Completion date
July 30, 2026
Enrollment
510 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid-19, covid-19 acute bronchitis, covid-19 acute respiratory distress syndrome, covid-19 lower respiratory infection, covid-19 pneumonia, covid-19 respiratory infection